내분비 교란 스크리닝 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00025912
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 226
Buy Now

내분비 교란 검사 시장은 2021년 1억 2,653만 달러에서 2028년 1억 5,330만 달러에 이를 것으로 예상됩니다. 2021년에서 2028년까지 CAGR 2.8%로 성장할 것으로 예상됩니다.



천연 및 인공의 많은 화학물질은 신체의 호르몬을 조절하는 내분비계를 모방하거나 방해할 가능성이 있습니다. . 내분비 교란 물질로 알려진 이러한 화학 물질은 발달, 생식, 뇌, 면역 및 기타 장애와 관련이 있습니다. 내분비 교란 물질은 일부 플라스틱 병 및 용기, 금속 식품 캔 라이너, 세제, 난연제, 식품, 장난감, 화장품 및 살충제와 같은 다양한 일반 품목에 존재할 수 있습니다. 살충제, 화학 물질 및 환경 독소는 내분비 교란 물질 스크리닝을 통해 에스트로겐, 안드로겐 및 갑상선 호르몬 시스템에 대한 잠재적 영향에 대해 2단계 방법을 사용하여 스크리닝합니다.



전략적 통찰력



내분비 교란 검사 시장의 성장은 생명 공학 분야의 연구 증가와 내분비 장애의 유병률 증가에 기인합니다. 그러나 높은 검사 기술 비용은 시장 성장을 방해합니다.



내분비 장애 검사 시장의 수익성 있는 지역



시장 통찰력내분비 장애의 증가하는 유병률이 내분비 장애 검사 시장을 주도



< p>말단 비대증(성장 호르몬 과잉 생산), 비만, 대사 증후군, 공복 혈당 장애, 내당능 장애, 골다공증, 골감소증, 경도-중등도 비타민 결핍증, 발기부전, 이상지질혈증 및 갑상선염은 집단적으로 유행하는 내분비 장애에 속합니다. 미국 성인 중 최소 5%. 이러한 상태 중 남성은 발기부전 발생률이 가장 높은 반면 여성은 골감소증/골다공증 발생률이 가장 높습니다. 어린이의 진성 당뇨병과 뇌하수체 선종은 미국 인구의 1% 미만에 영향을 미치는 가장 흔하지 않은 상태입니다. 부신피질 암종, 갈색 세포종 및 뇌하수체 선종은 발병률이 가장 낮은 상태입니다. 부갑상선기능항진증과 갑상선 질환은 여성에게 더 흔합니다. 진성 당뇨병은 소수 민족에서 가장 널리 퍼집니다. 내분비 및 대사 질환은 특히 미국 및 기타 국가에서 고위험 개인을 위한 충분한 영양 및 선별 프로그램을 시행하는 가장 흔한 현대인의 질병 중 하나입니다. 부갑상선기능항진증, 일차성 및 속발성 성선기능저하증, GH 결핍 및 갑상선기능저하증과 같은 내분비 장애는 대사성 골질환 및 진성 당뇨병과 같은 다른 장애를 유발할 수 있습니다. 따라서 이러한 질환의 유병률과 발생률이 증가함에 따라 내분비 교란 스크리닝 제품에 대한 수요가 증가하고 있습니다.



분석 유형 기반 통찰력



내분비 교란 스크리닝 시장은 분석 유형별로 두 갈래로 나뉩니다. 체외 및 생체 내. 체외 부문은 2021년 시장을 주도하여 64.45%의 시장 점유율에 기여했으며 예측 기간 동안 지배력을 유지하여 2028년에 생성된 전체 수익의 65.73%의 시장 점유율을 차지할 것으로 예상됩니다.

분석 유형별 내분비 교란 검사 시장 - 2021년 및 2028년



응용 기반 통찰력



응용 프로그램별로 내분비 교란 검사 시장은 천연 소재와 합성 재료. 2021년에는 천연 소재 부문이 시장에서 더 큰 점유율을 차지했습니다. 또한 동일한 부문의 시장은 2021-2028년 동안 3.1%의 더 빠른 CAGR로 성장할 것으로 예상됩니다.



폐기물 기반 통찰력의 출처



내분비 교란 검사 시장, 폐기물 공급원별로 소각 및 매립, 농업 유출수, 산업 및 도시 폐수, 펄프 공장 폐수, 소비재 등으로 분류됩니다. 2021년에는 소각 및 매립 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한, 동일한 세그먼트에 대한 시장은 2021-2028년 동안 3.5%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.



방법 기반 통찰력



방법별 내분비 교란 검사 시장 , 에스트로겐 수용체(ER) 전이활성화, 안드로겐 수용체(AR) 전이활성화, 안드로겐 수용체(AR) 조절, 에스트로겐 수용체-알파(ER) 결합, 에스트로겐 수용체 베타(ER) 결합, 안드로겐 수용체(AR) 결합, 스테로이드 생성으로 세분화됩니다. , aromatase 분석 및 기타. 2021년에는 에스트로겐 수용체(ER) 트랜스활성화 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한 동일한 부문의 시장은 2021년부터 2028년까지 가장 빠른 CAGR 3.7%로 성장할 것으로 예상됩니다.



최종 사용자 기반 통찰력



내분비 교란 검사 시장, 최종 용도에 따라 제약 및 바이오 제약 회사, 화장품 및 생활 용품 회사, 식품 산업 및 화학 산업으로 분류됩니다. 2021년에는 제약 및 바이오 제약 회사 부문이 시장에서 가장 큰 점유율을 차지했습니다. 또한 동일한 부문의 시장은 2021-2028년 동안 3.3%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.



제품 출시 및 승인은 기업이 글로벌 입지와 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략입니다. 또한 내분비 교란 검사 시장 참가자는 고객 확대를 위한 파트너십 전략에 초점을 맞추고 있으며, 이를 통해 전 세계적으로 브랜드 이름을 유지할 수 있습니다.



보고서는 내분비 교란 검사 시장을 다음과 같이 분류합니다.



내분비 교란 스크리닝 시장 – 분석 유형별





  • 체외

  • 체내


내분비 Disruption Screening 시장 - 용도별





  • 천연 재료

  • 합성 재료


내분비 교란 검사 시장 - 폐기물 발생원별



  • 소각 및 매립

  • 농업 유출수

  • 산업 및 도시 폐수

  • 펄프 공장 폐수

  • 소비재< /li>
  • 기타


내분비 교란 검사 시장 – 방법별





  • Estrogen Receptor(ER) Transactivation

  • Androgen Receptor (AR) Transactivation

  • 안드로겐 수용체(AR) 조절

  • 에스트로겐 수용체-알파(ER-alpha) 결합

  • 에스트로겐 수용체 베타(ER-beta) 결합

  • 안드로겐 수용체(AR) 결합

  • 스테로이드 생성

  • 아로마타아제 분석

  • 기타


내분비 Disruption Screening 시장 - 최종 사용자별





  • 제약 및 바이오 제약 회사

  • 화학 산업

  • 식품 산업

  • 화장품 및 가정용품 기업


내분비 교란 검사 시장 - 지역별





  • 북미

    • 미국

    • 캐나다

    • 멕시코



  • 유럽

    • 영국

    • 독일

    • 프랑스

    • 이탈리아

    • 스페인

    • 기타 유럽



  • 아시아 태평양

    • 중국

    • 일본

    • 인도

    • 호주

    • 한국

    • 기타 아시아 태평양



  • < li>중동 및 아프리카

    • UAE

    • 사우디아라비아

    • 남아프리카

    • 나머지 중동 및 아프리카


    • ul>
    • 중남미

      • 브라질

      • 아르헨티나

      • 나머지 중남미


      < /li>

    회사 프로필





    • CREATIVE BIOARRAY

    • XENOMETRIX AG

    • CHARLES RIVER LABORATORIES, INC.

    • EUROFINS SCIENTIFIC Ltd.

    • SMITHERS

    • SGS SA

    • JRF GLOBAL

    • MéRieux NUTRISCIENCES

    • ALPHA ANALYTICAL INC.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What does endocrine disruption screening mean?

Many chemicals, both natural and man-made, can imitate or interfere with the endocrine system, which regulates the body's hormones. These chemicals, known as endocrine disruptors, have been related to developmental, reproductive, cognitive, immunological, and other issues. Many ordinary products include endocrine disruptors, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Some hormone-disrupting compounds take a long time to degrade in the environment. As a result of this trait, they can become dangerous over time. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the estrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.

What are the driving factors for the endocrine disruption screening market across the globe?

The growth of the endocrine disruption screening market is mainly attributed to factors such as the increasing prevalence of endocrine disorders coupled with rising incidence of diabetes. However, the high cost of screening technology and devices is hindering the market growth. In July 2021, DDA platform, the division of Creative Bioarray, launched a wide range of genotoxicity testing services (non-GLP) into the service segment of in vitro toxicity services which is contributing to the growth of the target market. Such strategic steps are also projected to drive the market growth.

Which is the potential market for the endocrine disruption screening in terms of region??

The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market is this region is expected to grow significantly in countries such as China, Japan, South Korea, and India. The growth of the market in this region is expected to grow at a faster pace owing to factors such as high prevalence of this hormonal changes, and the rise in healthcare awareness. Additionally, developing healthcare infrastructure and increasing investments are projected to drive the Asia Pacific endocrine disruption screening market during the forecast period.

What are future trends of endocrine disruption screening market?

Regulatory agencies throughout the world are grappling with the task of assessing the hazards and dangers to human and ecosystem health that may come from exposure to substances that disrupt the normal functioning of endocrine systems. The rapidly rising number of compounds in commerce, along with the dependence on conventional, expensive animal tests for hazard assessment – frequently with insufficient sensitivity to many critical processes of endocrine disruption – poses persistent problems for chemical management. As a result, there are only a few compounds for which there is enough evidence to determine whether there is endocrine toxicity, and hence only a few substances with full hazard categorization. To address this issue, regulatory assessment of endocrine disrupting chemicals (EDCs) is benefiting from a toxicology revolution focused on New Approach Methodologies (NAMs) to more rapidly identify, prioritize, and assess the potential risks from chemical exposure using novel, more efficient, and mechanistically driven methodologies, and tools.

What is the market CAGR value of endocrine disruption screening market during forecast period?

The global endocrine disruption screening market is expected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021. The market is estimated to grow with a CAGR of 2.8% from 2021-2028.

The List of Companies - Endocrine Disruption Screening Market

  1. CREATIVE BIOARRAY
  2. XENOMETRIX AG
  3. CHARLES RIVER
  4. EUROFINS SCIENTIFIC
  5. SMITHERS
  6. SGS SA
  7. JRF GLOBAL
  8. MéRIEUX NUTRISCIENCES
  9. ALPHA ANALYTICAL

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports